May 30, 2026
6 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
CHICAGO — Treating resected brain metastases with cesium-131 tile-based radiation therapy immediately after surgery significantly improved local recurrence and survival compared with standard of care.The findings from a phase 3 randomized trial, presented at ASCO Annual Meeting, showed patients who received the tile therapy had a 93% improvement in surgical bed recurrence and a 41%
May 30, 2026
6 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Tile-Based Radiation Tops Standard for Resected Brain Metastases

ROADS Phase 3 Clinical Trial Data Presented at ASCO26 Show GammaTile® Provides Superior Tumor Control Leading to Patients Living Longer Without Recurrence Compared to Standard of Care in Newly Diagnosed Operable Brain Metastases

Emerging therapies for CNS tumours: key clinical trial updates to watch at ASCO 2026 - Pharmaceutical Technology

Cancer trial shows promising results for treatment-resistant tumors

Targeted Combo Boosts PFS in BRAF-Mutant Metastatic Colorectal Cancer

'Immediately Practice-Changing' Lung Cancer Trial in Curative Setting

Approach significantly improved local control, and longer survival observed in trial

ROADS Phase 3 Clinical Trial Data Presented at ASCO26 Show GammaTile® Provides Superior Tumor Control Leading to Patients Living…

Preoperative radiation therapy targeting brain metastases can activate immune pathways that typically are suppressed, results of…

Experts discuss biologic targeting, dose escalation, and the promise of precision radiotherapy

Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center and Roswell Park Comprehensive Cancer Center have developed…

Experts discuss how advanced MRI is influencing surgical and radiation treatment decisions